MCRB Financial Statements

Balance sheet, income statement, cash flow, and dividends for Seres Therapeutics Inc (MCRB).


$141.88M Market Cap.

As of 03/13/2025 5:00 PM ET (MRY) • Disclaimer

MCRB Market Cap. (MRY)


MCRB Shares Outstanding (MRY)


MCRB Assets (MRY)


Total Assets

$139.81M

Total Liabilities

$126.03M

Total Investments

$0

MCRB Income (MRY)


Revenue

$0

Net Income

$136.00K

Operating Expense

$121.31M

MCRB Cash Flow (MRY)


CF Operations

-$148.61M

CF Investing

$142.29M

CF Financing

-$90.37M

MCRB Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

-

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

MCRB Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$139,810,000 (-61.01%)

$358,600,000 (2.81%)

$348,784,000 (-1.71%)

$354,859,000 (3.48%)

Assets Current

$38,674,000 (-77.95%)

$175,410,000 (-9.94%)

$194,764,000 (-35.85%)

$303,628,000 (12.97%)

Assets Non-Current

$101,136,000 (-44.79%)

$183,190,000 (18.94%)

$154,020,000 (200.64%)

$51,231,000 (-30.92%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$13,784,000 (130.73%)

-$44,856,000 (-515.99%)

$10,783,000 (-91.80%)

$131,507,000 (-24.75%)

Property Plant & Equipment Net

$92,437,000 (-30.10%)

$132,250,000 (-1.28%)

$133,969,000 (270.63%)

$36,146,000 (57.58%)

Cash & Equivalents

$39,461,000 (-71.02%)

$136,150,000 (-20.48%)

$171,215,000 (-8.93%)

$188,002,000 (62.00%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

-$12,000 (80.00%)

-$60,000 (-27.66%)

Deferred Revenue

$0 (0%)

$103,094,000 (6.62%)

$96,689,000 (-6.87%)

$103,817,000 (-4.03%)

Total Investments

$0 (0%)

$1,401,000 (-92.89%)

$19,712,000 (-82.49%)

$112,600,000 (-40.36%)

Investments Current

$0 (0%)

$0 (0%)

$18,311,000 (-83.46%)

$110,704,000 (-19.53%)

Investments Non-Current

$0 (0%)

$1,401,000 (0.00%)

$1,401,000 (-26.11%)

$1,896,000 (-96.30%)

Inventory

$0 (0%)

$29,647,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$2,068,000 (-76.16%)

$8,674,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$4,079,000 (12.03%)

$3,641,000 (-79.12%)

$17,440,000 (26.97%)

$13,735,000 (241.84%)

Accumulated Retained Earnings (Deficit)

-$978,099,000 (0.01%)

-$978,235,000 (-13.15%)

-$864,511,000 (-40.72%)

-$614,354,000 (-11.95%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$91,640,000 (-57.16%)

$213,936,000 (31.58%)

$162,590,000 (230.39%)

$49,211,000 (20.71%)

Debt Current

$8,674,000 (29.91%)

$6,677,000 (64.58%)

$4,057,000 (-38.62%)

$6,610,000 (18.69%)

Debt Non-Current

$82,966,000 (-59.97%)

$207,259,000 (30.74%)

$158,533,000 (272.13%)

$42,601,000 (21.03%)

Total Liabilities

$126,026,000 (-68.76%)

$403,456,000 (19.37%)

$338,001,000 (51.33%)

$223,352,000 (32.80%)

Liabilities Current

$41,222,000 (-58.22%)

$98,659,000 (15.26%)

$85,596,000 (4.06%)

$82,258,000 (77.22%)

Liabilities Non-Current

$84,804,000 (-72.18%)

$304,797,000 (20.76%)

$252,405,000 (78.89%)

$141,094,000 (15.86%)

MCRB Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$126,325,000 (1672.24%)

$7,128,000 (-95.08%)

$144,927,000 (336.33%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$53,183,000 (-39.39%)

$87,744,000 (10.10%)

$79,694,000 (15.06%)

$69,261,000 (125.06%)

Research & Development Expense

$64,600,000 (-55.71%)

$145,860,000 (-15.65%)

$172,920,000 (21.87%)

$141,891,000 (56.66%)

Operating Expenses

$121,315,000 (-48.22%)

$234,308,000 (-7.61%)

$253,618,000 (21.10%)

$209,420,000 (72.58%)

Interest Expense

$0 (0%)

$13,176,000 (118.87%)

$6,020,000 (106.87%)

$2,910,000 (-0.48%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

-$125,907,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$136,000 (100.12%)

-$113,724,000 (54.54%)

-$250,157,000 (-281.46%)

-$65,578,000 (26.42%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$136,000 (100.12%)

-$113,724,000 (54.54%)

-$250,157,000 (-281.46%)

-$65,578,000 (26.42%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$136,000 (100.12%)

-$113,724,000 (54.54%)

-$250,157,000 (-281.46%)

-$65,578,000 (26.42%)

Weighted Average Shares

$155,400,760 (21.40%)

$128,003,294 (18.44%)

$108,077,043 (17.86%)

$91,702,866 (14.93%)

Weighted Average Shares Diluted

$155,400,760 (21.40%)

$128,003,294 (18.44%)

$108,077,043 (17.86%)

$91,702,866 (14.93%)

Earning Before Interest & Taxes (EBIT)

$136,000 (100.14%)

-$100,548,000 (58.81%)

-$244,137,000 (-289.57%)

-$62,668,000 (27.30%)

Gross Profit

$0 (0%)

$126,325,000 (1672.24%)

$7,128,000 (-95.08%)

$144,927,000 (336.33%)

Operating Income

-$121,315,000 (-12.35%)

-$107,983,000 (56.19%)

-$246,490,000 (-282.20%)

-$64,493,000 (26.82%)

MCRB Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$142,293,000 (1244.67%)

$10,582,000 (-87.16%)

$82,428,000 (28.62%)

$64,088,000 (140.33%)

Net Cash Flow from Financing

-$90,372,000 (-226.03%)

$71,705,000 (-44.67%)

$129,602,000 (10901.87%)

$1,178,000 (-99.61%)

Net Cash Flow from Operations

-$148,609,000 (-26.63%)

-$117,354,000 (48.71%)

-$228,816,000 (-3521.29%)

$6,688,000 (107.14%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$96,688,000 (-175.72%)

-$35,067,000 (-108.91%)

-$16,786,000 (-123.33%)

$71,954,000 (41.30%)

Net Cash Flow - Business Acquisitions and Disposals

$141,272,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$1,401,000 (-92.45%)

$18,557,000 (-79.88%)

$92,249,000 (25.25%)

$73,654,000 (146.53%)

Capital Expenditure

-$380,000 (95.24%)

-$7,975,000 (18.80%)

-$9,821,000 (-2.67%)

-$9,566,000 (-1518.61%)

Issuance (Repayment) of Debt Securities

-$127,905,000 (-353.19%)

$50,518,000 (96.58%)

$25,699,000 (2810.86%)

-$948,000 (0%)

Issuance (Purchase) of Equity Shares

$37,533,000 (77.15%)

$21,187,000 (-79.61%)

$103,903,000 (4787.25%)

$2,126,000 (-99.30%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$1,000 (-150.00%)

$2,000 (300.00%)

-$1,000 (0.00%)

-$1,000 (0%)

Share Based Compensation

$20,971,000 (-38.50%)

$34,101,000 (33.82%)

$25,482,000 (26.01%)

$20,222,000 (129.17%)

Depreciation Amortization & Accretion

$14,698,000 (-2.75%)

$15,114,000 (27.51%)

$11,853,000 (28.53%)

$9,222,000 (3.70%)

MCRB Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-

-90.00% (97.44%)

-3509.50% (-7664.38%)

-45.20% (83.15%)

EBITDA Margin

-

-67.60% (97.93%)

-3258.80% (-8731.44%)

-36.90% (84.15%)

Return on Average Equity (ROAE)

-0.50% (-100.09%)

533.70% (197.28%)

-548.60% (-1054.95%)

-47.50% (68.61%)

Return on Average Assets (ROAA)

0.10% (100.31%)

-32.40% (59.40%)

-79.80% (-303.03%)

-19.80% (49.49%)

Return on Sales (ROS)

-

-79.60% (97.68%)

-3425.00% (-7828.24%)

-43.20% (83.35%)

Return on Invested Capital (ROIC)

0.10% (100.31%)

-32.70% (79.00%)

-155.70% (-314.10%)

-37.60% (49.93%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-

-1.57 (35.11%)

-2.42 (79.05%)

-11.57 (47.11%)

Price to Sales Ratio (P/S)

-

1.42 (-98.33%)

84.91 (1510.87%)

5.27 (-91.04%)

Price to Book Ratio (P/B)

10.29 (355.16%)

-4.03 (-106.23%)

64.7 (1012.15%)

5.82 (-54.52%)

Debt to Equity Ratio (D/E)

9.14 (201.66%)

-8.99 (-128.69%)

31.35 (1746.05%)

1.7 (76.51%)

Earnings Per Share (EPS)

0 (0%)

-0.89 (61.47%)

-2.31 (-220.83%)

-0.72 (35.71%)

Sales Per Share (SPS)

0 (0%)

0.99 (1395.45%)

0.07 (-95.82%)

1.58 (279.81%)

Free Cash Flow Per Share (FCFPS)

-0.96 (2.04%)

-0.98 (55.66%)

-2.21 (-7022.58%)

-0.03 (97.38%)

Book Value Per Share (BVPS)

0.09 (125.43%)

-0.35 (-450.00%)

0.1 (-93.03%)

1.43 (-34.52%)

Tangible Assets Book Value Per Share (TABVPS)

0.9 (-67.87%)

2.8 (-13.20%)

3.23 (-16.61%)

3.87 (-9.96%)

Enterprise Value Over EBIT (EV/EBIT)

1,168 (58500.00%)

-2 (0.00%)

-2 (77.78%)

-9 (62.50%)

Enterprise Value Over EBITDA (EV/EBITDA)

10.71 (525.14%)

-2.52 (-4.39%)

-2.41 (77.83%)

-10.88 (59.37%)

Asset Turnover

0 (0%)

0.36 (1465.22%)

0.02 (-94.74%)

0.44 (199.32%)

Current Ratio

0.94 (-47.24%)

1.78 (-21.85%)

2.27 (-38.36%)

3.69 (-36.26%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$148,989,000 (-18.88%)

-$125,329,000 (47.48%)

-$238,637,000 (-8191.77%)

-$2,878,000 (96.94%)

Enterprise Value (EV)

$158,798,335 (-26.19%)

$215,141,079 (-61.59%)

$560,170,750 (-3.65%)

$581,418,651 (-71.91%)

Earnings Before Tax (EBT)

$136,000 (100.12%)

-$113,724,000 (54.54%)

-$250,157,000 (-281.46%)

-$65,578,000 (26.42%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$14,834,000 (117.36%)

-$85,434,000 (63.22%)

-$232,284,000 (-334.61%)

-$53,446,000 (30.87%)

Invested Capital

$150,767,000 (-55.36%)

$337,727,000 (32.67%)

$254,563,000 (90.24%)

$133,810,000 (-39.52%)

Working Capital

-$2,548,000 (-103.32%)

$76,751,000 (-29.69%)

$109,168,000 (-50.69%)

$221,370,000 (-0.45%)

Tangible Asset Value

$139,810,000 (-61.01%)

$358,600,000 (2.81%)

$348,784,000 (-1.71%)

$354,859,000 (3.48%)

Market Capitalization

$141,883,335 (-21.59%)

$180,960,079 (-74.06%)

$697,713,750 (-8.81%)

$765,086,651 (-65.78%)

Average Equity

-$27,277,250 (-28.01%)

-$21,309,000 (-146.73%)

$45,595,500 (-66.96%)

$138,004,000 (134.32%)

Average Assets

$245,386,250 (-30.03%)

$350,720,000 (11.90%)

$313,434,250 (-5.48%)

$331,623,750 (45.70%)

Invested Capital Average

$240,978,250 (-21.64%)

$307,536,000 (96.13%)

$156,802,500 (-5.98%)

$166,768,750 (45.22%)

Shares

170,738,069 (32.09%)

129,257,199 (3.74%)

124,591,741 (35.65%)

91,847,137 (0.66%)